Parametric Portfolio Associates’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.64M | Sell |
32,298
-11,435
| -26% | -$581K | ﹤0.01% | 2526 |
|
|
2021
Q4 | $2.07M | Sell |
43,733
-6,157
| -12% | -$291K | ﹤0.01% | 2418 |
|
|
2021
Q3 | $1.64M | Sell |
49,890
-7,858
| -14% | -$259K | ﹤0.01% | 2542 |
|
|
2021
Q2 | $3.65M | Buy |
57,748
+26,858
| +87% | +$1.7M | ﹤0.01% | 2066 |
|
|
2021
Q1 | $1.33M | Sell |
30,890
-21,903
| -41% | -$940K | ﹤0.01% | 3027 |
|
|
2020
Q4 | $3.02M | Buy |
52,793
+31,167
| +144% | +$1.78M | ﹤0.01% | 2399 |
|
|
2020
Q3 | $652K | Sell |
21,626
-9,178
| -30% | -$277K | ﹤0.01% | 3138 |
|
|
2020
Q2 | $1.01M | Buy |
30,804
+20,854
| +210% | +$681K | ﹤0.01% | 2918 |
|
|
2020
Q1 | $267K | Buy |
9,950
+409
| +4% | +$11K | ﹤0.01% | 3435 |
|
|
2019
Q4 | $292K | Sell |
9,541
-759
| -7% | -$23.2K | ﹤0.01% | 3576 |
|
|
2019
Q3 | $248K | Buy |
+10,300
| New | +$248K | ﹤0.01% | 3627 |
|